Structure

Physi-Chem Properties

Molecular Weight:  236.07
Volume:  229.764
LogP:  1.756
LogD:  1.511
LogS:  -2.243
# Rotatable Bonds:  2
TPSA:  68.9
# H-Bond Aceptor:  5
# H-Bond Donor:  1
# Rings:  2
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.861
Synthetic Accessibility Score:  2.339
Fsp3:  0.25
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.773
MDCK Permeability:  1.8009543055086397e-05
Pgp-inhibitor:  0.024
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.011
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.007

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.188
Plasma Protein Binding (PPB):  76.67730712890625%
Volume Distribution (VD):  0.874
Pgp-substrate:  20.974870681762695%

ADMET: Metabolism

CYP1A2-inhibitor:  0.923
CYP1A2-substrate:  0.974
CYP2C19-inhibitor:  0.195
CYP2C19-substrate:  0.865
CYP2C9-inhibitor:  0.211
CYP2C9-substrate:  0.828
CYP2D6-inhibitor:  0.039
CYP2D6-substrate:  0.835
CYP3A4-inhibitor:  0.14
CYP3A4-substrate:  0.485

ADMET: Excretion

Clearance (CL):  4.902
Half-life (T1/2):  0.75

ADMET: Toxicity

hERG Blockers:  0.051
Human Hepatotoxicity (H-HT):  0.08
Drug-inuced Liver Injury (DILI):  0.425
AMES Toxicity:  0.427
Rat Oral Acute Toxicity:  0.243
Maximum Recommended Daily Dose:  0.069
Skin Sensitization:  0.55
Carcinogencity:  0.041
Eye Corrosion:  0.021
Eye Irritation:  0.784
Respiratory Toxicity:  0.258

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC30647

Natural Product ID:  NPC30647
Common Name*:   Stellatin
IUPAC Name:   5-hydroxy-6,7-dimethoxy-2-methylchromen-4-one
Synonyms:   Stellatin
Standard InCHIKey:  PJCFJNHVNWMRPD-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C12H12O5/c1-6-4-7(13)10-8(17-6)5-9(15-2)12(16-3)11(10)14/h4-5,14H,1-3H3
SMILES:  Cc1cc(=O)c2c(cc(c(c2O)OC)OC)o1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1684136
PubChem CID:   53322523
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0000144] Chromones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25983 Pisonia aculeata Species Nyctaginaceae Eukaryota n.a. root n.a. PMID[21542597]
NPO25983 Pisonia aculeata Species Nyctaginaceae Eukaryota n.a. stem n.a. PMID[21542597]
NPO25983 Pisonia aculeata Species Nyctaginaceae Eukaryota n.a. n.a. n.a. PMID[21542597]
NPO501 Mycoleptodiscus indicus Species Magnaporthaceae Eukaryota n.a. n.a. n.a. PMID[24387625]
NPO25983 Pisonia aculeata Species Nyctaginaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO501 Mycoleptodiscus indicus Species Magnaporthaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT30 Individual Protein Cyclooxygenase-1 Homo sapiens Inhibition = 71.5 % PMID[478292]
NPT31 Individual Protein Cyclooxygenase-2 Homo sapiens Inhibition = 80.15 % PMID[478292]
NPT30 Individual Protein Cyclooxygenase-1 Homo sapiens IC50 = 22300.0 nM PMID[478292]
NPT31 Individual Protein Cyclooxygenase-2 Homo sapiens IC50 = 19700.0 nM PMID[478292]
NPT399 Cell Line SF-295 Homo sapiens IC50 > 105000.0 nM PMID[478293]
NPT306 Cell Line PC-3 Homo sapiens IC50 = 20500.0 nM PMID[478293]
NPT116 Cell Line HL-60 Homo sapiens IC50 > 105000.0 nM PMID[478293]
NPT400 Cell Line MDA-MB-435 Homo sapiens IC50 > 105000.0 nM PMID[478293]
NPT32 Organism Mus musculus Mus musculus Activity = 0.082 mm PMID[478292]
NPT32 Organism Mus musculus Mus musculus Inhibition = 69.44 % PMID[478292]
NPT27 Others Unspecified IC50 > 105000.0 nM PMID[478293]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 105000.0 nM PMID[478293]
NPT633 Organism Leishmania donovani Leishmania donovani IC50 > 169000.0 nM PMID[478293]
NPT841 Organism Leishmania major Leishmania major LD50 = 34.5 uM PMID[478293]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC30647 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC55557
1.0 High Similarity NPC61871
0.9655 High Similarity NPC188203
0.9655 High Similarity NPC241498
0.9655 High Similarity NPC275836
0.9655 High Similarity NPC131624
0.9655 High Similarity NPC198826
0.9655 High Similarity NPC57030
0.9655 High Similarity NPC275722
0.9655 High Similarity NPC83508
0.9655 High Similarity NPC212678
0.9655 High Similarity NPC120163
0.9655 High Similarity NPC71334
0.9655 High Similarity NPC301323
0.9655 High Similarity NPC25270
0.9655 High Similarity NPC156222
0.9655 High Similarity NPC100887
0.9655 High Similarity NPC256283
0.9655 High Similarity NPC293183
0.9655 High Similarity NPC239128
0.9655 High Similarity NPC162313
0.9655 High Similarity NPC222830
0.9655 High Similarity NPC187498
0.9589 High Similarity NPC250822
0.9589 High Similarity NPC276409
0.9589 High Similarity NPC47781
0.9589 High Similarity NPC22519
0.9589 High Similarity NPC69394
0.9589 High Similarity NPC274327
0.9589 High Similarity NPC183878
0.9589 High Similarity NPC145379
0.9589 High Similarity NPC75279
0.9589 High Similarity NPC255350
0.9589 High Similarity NPC160951
0.9589 High Similarity NPC176775
0.9589 High Similarity NPC231018
0.9583 High Similarity NPC259713
0.9583 High Similarity NPC216318
0.9583 High Similarity NPC296197
0.9583 High Similarity NPC17286
0.958 High Similarity NPC251188
0.9577 High Similarity NPC472917
0.9524 High Similarity NPC2476
0.9524 High Similarity NPC138360
0.9524 High Similarity NPC280339
0.9524 High Similarity NPC18954
0.9524 High Similarity NPC4455
0.9524 High Similarity NPC201451
0.9524 High Similarity NPC26227
0.9524 High Similarity NPC163780
0.9524 High Similarity NPC50715
0.9524 High Similarity NPC227325
0.9524 High Similarity NPC20830
0.9524 High Similarity NPC183597
0.9524 High Similarity NPC128863
0.9524 High Similarity NPC44079
0.9524 High Similarity NPC201136
0.9524 High Similarity NPC196439
0.9524 High Similarity NPC146165
0.9524 High Similarity NPC256612
0.9524 High Similarity NPC213622
0.9524 High Similarity NPC167815
0.9524 High Similarity NPC208197
0.9524 High Similarity NPC92659
0.9521 High Similarity NPC101996
0.9521 High Similarity NPC142540
0.9521 High Similarity NPC199100
0.9521 High Similarity NPC180234
0.9521 High Similarity NPC120537
0.9517 High Similarity NPC184136
0.9517 High Similarity NPC306821
0.9517 High Similarity NPC45873
0.9514 High Similarity NPC120464
0.951 High Similarity NPC143903
0.951 High Similarity NPC226987
0.9459 High Similarity NPC474520
0.9459 High Similarity NPC245546
0.9459 High Similarity NPC49824
0.9459 High Similarity NPC98661
0.9459 High Similarity NPC43243
0.9459 High Similarity NPC247017
0.9459 High Similarity NPC266960
0.9459 High Similarity NPC317383
0.9456 High Similarity NPC292214
0.9456 High Similarity NPC88645
0.9456 High Similarity NPC271779
0.9456 High Similarity NPC167091
0.9456 High Similarity NPC206238
0.9452 High Similarity NPC225731
0.9452 High Similarity NPC208043
0.9452 High Similarity NPC226973
0.9452 High Similarity NPC171010
0.9448 High Similarity NPC328119
0.9448 High Similarity NPC48479
0.9448 High Similarity NPC183950
0.9448 High Similarity NPC177298
0.9448 High Similarity NPC52005
0.9448 High Similarity NPC137062
0.9448 High Similarity NPC287101
0.9448 High Similarity NPC223579
0.9444 High Similarity NPC275772
0.9444 High Similarity NPC130230
0.9444 High Similarity NPC239312
0.9396 High Similarity NPC93376
0.9396 High Similarity NPC110070
0.9396 High Similarity NPC227192
0.9396 High Similarity NPC203891
0.9396 High Similarity NPC189179
0.9396 High Similarity NPC163524
0.9396 High Similarity NPC470402
0.9396 High Similarity NPC75215
0.9396 High Similarity NPC101830
0.9396 High Similarity NPC472438
0.9396 High Similarity NPC7973
0.9396 High Similarity NPC176665
0.9396 High Similarity NPC224137
0.9396 High Similarity NPC78302
0.9396 High Similarity NPC29841
0.9396 High Similarity NPC305663
0.9396 High Similarity NPC287979
0.9396 High Similarity NPC235215
0.9392 High Similarity NPC2928
0.9388 High Similarity NPC39732
0.9388 High Similarity NPC39007
0.9388 High Similarity NPC60972
0.9388 High Similarity NPC161277
0.9388 High Similarity NPC27208
0.9388 High Similarity NPC301123
0.9384 High Similarity NPC179183
0.9384 High Similarity NPC62042
0.9384 High Similarity NPC61620
0.9379 High Similarity NPC12367
0.9379 High Similarity NPC118726
0.9379 High Similarity NPC287395
0.9379 High Similarity NPC183655
0.9333 High Similarity NPC261004
0.9333 High Similarity NPC19687
0.9333 High Similarity NPC105242
0.9333 High Similarity NPC9609
0.9333 High Similarity NPC4481
0.9333 High Similarity NPC204854
0.9333 High Similarity NPC7846
0.9333 High Similarity NPC472886
0.9333 High Similarity NPC143828
0.9333 High Similarity NPC18607
0.9333 High Similarity NPC22472
0.9333 High Similarity NPC152166
0.9333 High Similarity NPC18772
0.9333 High Similarity NPC176300
0.9333 High Similarity NPC253634
0.9333 High Similarity NPC191459
0.9333 High Similarity NPC288669
0.9333 High Similarity NPC130894
0.9333 High Similarity NPC300943
0.9333 High Similarity NPC115798
0.9333 High Similarity NPC25495
0.9329 High Similarity NPC235165
0.9329 High Similarity NPC292107
0.9329 High Similarity NPC200388
0.9329 High Similarity NPC472916
0.9329 High Similarity NPC268161
0.9329 High Similarity NPC55619
0.9329 High Similarity NPC100916
0.9329 High Similarity NPC255106
0.9324 High Similarity NPC86485
0.9324 High Similarity NPC280937
0.932 High Similarity NPC45291
0.932 High Similarity NPC125062
0.932 High Similarity NPC149614
0.932 High Similarity NPC19980
0.932 High Similarity NPC200740
0.932 High Similarity NPC252933
0.932 High Similarity NPC308451
0.932 High Similarity NPC251110
0.932 High Similarity NPC54394
0.932 High Similarity NPC50403
0.932 High Similarity NPC117579
0.932 High Similarity NPC133953
0.932 High Similarity NPC28274
0.9315 High Similarity NPC92722
0.9315 High Similarity NPC102003
0.9315 High Similarity NPC195351
0.931 High Similarity NPC168803
0.931 High Similarity NPC12200
0.931 High Similarity NPC33265
0.931 High Similarity NPC62536
0.931 High Similarity NPC108406
0.9301 High Similarity NPC175013
0.9272 High Similarity NPC476980
0.9272 High Similarity NPC246478
0.9267 High Similarity NPC262286
0.9267 High Similarity NPC162869
0.9267 High Similarity NPC472911
0.9267 High Similarity NPC96167
0.9267 High Similarity NPC472914
0.9267 High Similarity NPC472913
0.9267 High Similarity NPC99597
0.9267 High Similarity NPC78225
0.9267 High Similarity NPC474208
0.9267 High Similarity NPC222814

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC30647 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9589 High Similarity NPD2801 Approved
0.9236 High Similarity NPD1511 Approved
0.9128 High Similarity NPD1934 Approved
0.911 High Similarity NPD1512 Approved
0.8947 High Similarity NPD3882 Suspended
0.8816 High Similarity NPD2393 Clinical (unspecified phase)
0.8636 High Similarity NPD3817 Phase 2
0.8562 High Similarity NPD3818 Discontinued
0.8553 High Similarity NPD6168 Clinical (unspecified phase)
0.8553 High Similarity NPD6167 Clinical (unspecified phase)
0.8553 High Similarity NPD6166 Phase 2
0.8528 High Similarity NPD4338 Clinical (unspecified phase)
0.8509 High Similarity NPD7054 Approved
0.8503 High Similarity NPD970 Clinical (unspecified phase)
0.8457 Intermediate Similarity NPD7472 Approved
0.8411 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8365 Intermediate Similarity NPD1247 Approved
0.8345 Intermediate Similarity NPD230 Phase 1
0.8344 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD7074 Phase 3
0.8311 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8311 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8302 Intermediate Similarity NPD5494 Approved
0.8299 Intermediate Similarity NPD1510 Phase 2
0.8293 Intermediate Similarity NPD6797 Phase 2
0.8276 Intermediate Similarity NPD1240 Approved
0.8276 Intermediate Similarity NPD943 Approved
0.8255 Intermediate Similarity NPD1549 Phase 2
0.8242 Intermediate Similarity NPD7251 Discontinued
0.8219 Intermediate Similarity NPD447 Suspended
0.8217 Intermediate Similarity NPD1465 Phase 2
0.8193 Intermediate Similarity NPD7808 Phase 3
0.8163 Intermediate Similarity NPD1607 Approved
0.8141 Intermediate Similarity NPD4380 Phase 2
0.8105 Intermediate Similarity NPD6799 Approved
0.8086 Intermediate Similarity NPD6232 Discontinued
0.8079 Intermediate Similarity NPD2800 Approved
0.8063 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8054 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.805 Intermediate Similarity NPD5402 Approved
0.8049 Intermediate Similarity NPD7473 Discontinued
0.8012 Intermediate Similarity NPD919 Approved
0.8 Intermediate Similarity NPD2796 Approved
0.795 Intermediate Similarity NPD7075 Discontinued
0.7935 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7931 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7931 Intermediate Similarity NPD9494 Approved
0.7877 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7875 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7844 Intermediate Similarity NPD5844 Phase 1
0.7821 Intermediate Similarity NPD2533 Approved
0.7821 Intermediate Similarity NPD2532 Approved
0.7821 Intermediate Similarity NPD2534 Approved
0.7818 Intermediate Similarity NPD3926 Phase 2
0.7812 Intermediate Similarity NPD6801 Discontinued
0.7799 Intermediate Similarity NPD6599 Discontinued
0.7792 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD1653 Approved
0.7785 Intermediate Similarity NPD1613 Approved
0.7764 Intermediate Similarity NPD7819 Suspended
0.7763 Intermediate Similarity NPD1551 Phase 2
0.7763 Intermediate Similarity NPD2935 Discontinued
0.7738 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD1243 Approved
0.7722 Intermediate Similarity NPD920 Approved
0.7716 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7708 Intermediate Similarity NPD9269 Phase 2
0.7697 Intermediate Similarity NPD6959 Discontinued
0.7677 Intermediate Similarity NPD3750 Approved
0.764 Intermediate Similarity NPD7411 Suspended
0.761 Intermediate Similarity NPD5403 Approved
0.7595 Intermediate Similarity NPD5401 Approved
0.7595 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD3027 Phase 3
0.7566 Intermediate Similarity NPD6651 Approved
0.7533 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD422 Phase 1
0.7515 Intermediate Similarity NPD3749 Approved
0.75 Intermediate Similarity NPD6559 Discontinued
0.75 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD2344 Approved
0.7468 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7466 Intermediate Similarity NPD9717 Approved
0.7432 Intermediate Similarity NPD1203 Approved
0.7431 Intermediate Similarity NPD9268 Approved
0.7419 Intermediate Similarity NPD6100 Approved
0.7419 Intermediate Similarity NPD6099 Approved
0.7415 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7401 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7386 Intermediate Similarity NPD1933 Approved
0.7368 Intermediate Similarity NPD3751 Discontinued
0.7365 Intermediate Similarity NPD6234 Discontinued
0.7355 Intermediate Similarity NPD3748 Approved
0.7353 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD7768 Phase 2
0.7342 Intermediate Similarity NPD4628 Phase 3
0.7312 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD411 Approved
0.7303 Intermediate Similarity NPD2313 Discontinued
0.7301 Intermediate Similarity NPD3226 Approved
0.7296 Intermediate Similarity NPD2309 Approved
0.7296 Intermediate Similarity NPD6190 Approved
0.7289 Intermediate Similarity NPD5353 Approved
0.7278 Intermediate Similarity NPD7199 Phase 2
0.7278 Intermediate Similarity NPD2654 Approved
0.7278 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7251 Intermediate Similarity NPD2403 Approved
0.7244 Intermediate Similarity NPD2799 Discontinued
0.7241 Intermediate Similarity NPD5953 Discontinued
0.7241 Intermediate Similarity NPD1548 Phase 1
0.7235 Intermediate Similarity NPD3787 Discontinued
0.7235 Intermediate Similarity NPD5710 Approved
0.7235 Intermediate Similarity NPD5711 Approved
0.7234 Intermediate Similarity NPD228 Approved
0.7233 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7286 Phase 2
0.7193 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD37 Approved
0.7161 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD2346 Discontinued
0.7143 Intermediate Similarity NPD4966 Approved
0.7143 Intermediate Similarity NPD4965 Approved
0.7143 Intermediate Similarity NPD4967 Phase 2
0.7135 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD9545 Approved
0.7114 Intermediate Similarity NPD1608 Approved
0.7103 Intermediate Similarity NPD9493 Approved
0.7102 Intermediate Similarity NPD7685 Pre-registration
0.7099 Intermediate Similarity NPD7390 Discontinued
0.7093 Intermediate Similarity NPD5242 Approved
0.7078 Intermediate Similarity NPD1296 Phase 2
0.7069 Intermediate Similarity NPD7228 Approved
0.7066 Intermediate Similarity NPD6844 Discontinued
0.7063 Intermediate Similarity NPD1652 Phase 2
0.7059 Intermediate Similarity NPD6832 Phase 2
0.7047 Intermediate Similarity NPD1610 Phase 2
0.7047 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD1019 Discontinued
0.7014 Intermediate Similarity NPD1241 Discontinued
0.7006 Intermediate Similarity NPD6385 Approved
0.7006 Intermediate Similarity NPD6386 Approved
0.7 Intermediate Similarity NPD1481 Phase 2
0.6994 Remote Similarity NPD4357 Discontinued
0.6993 Remote Similarity NPD3018 Phase 2
0.6968 Remote Similarity NPD3268 Approved
0.6954 Remote Similarity NPD4749 Approved
0.6951 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6948 Remote Similarity NPD4908 Phase 1
0.6939 Remote Similarity NPD5536 Phase 2
0.6933 Remote Similarity NPD1535 Discovery
0.6928 Remote Similarity NPD2798 Approved
0.6923 Remote Similarity NPD6233 Phase 2
0.6918 Remote Similarity NPD7033 Discontinued
0.6918 Remote Similarity NPD4308 Phase 3
0.6913 Remote Similarity NPD17 Approved
0.6909 Remote Similarity NPD1940 Clinical (unspecified phase)
0.6908 Remote Similarity NPD3225 Approved
0.6906 Remote Similarity NPD8434 Phase 2
0.6894 Remote Similarity NPD2424 Discontinued
0.6886 Remote Similarity NPD824 Approved
0.6882 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6879 Remote Similarity NPD1558 Phase 1
0.6871 Remote Similarity NPD405 Clinical (unspecified phase)
0.6867 Remote Similarity NPD3496 Discontinued
0.6865 Remote Similarity NPD4360 Phase 2
0.6865 Remote Similarity NPD4363 Phase 3
0.6863 Remote Similarity NPD2797 Approved
0.6863 Remote Similarity NPD1470 Approved
0.6862 Remote Similarity NPD6782 Approved
0.6862 Remote Similarity NPD6780 Approved
0.6862 Remote Similarity NPD6778 Approved
0.6862 Remote Similarity NPD6777 Approved
0.6862 Remote Similarity NPD6781 Approved
0.6862 Remote Similarity NPD6779 Approved
0.6862 Remote Similarity NPD6776 Approved
0.6859 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6842 Remote Similarity NPD2983 Phase 2
0.6842 Remote Similarity NPD2982 Phase 2
0.6839 Remote Similarity NPD1008 Clinical (unspecified phase)
0.6833 Remote Similarity NPD8313 Approved
0.6833 Remote Similarity NPD8312 Approved
0.6832 Remote Similarity NPD1471 Phase 3
0.6821 Remote Similarity NPD1201 Approved
0.6803 Remote Similarity NPD6671 Approved
0.68 Remote Similarity NPD1778 Approved
0.6798 Remote Similarity NPD1729 Discontinued
0.6784 Remote Similarity NPD2899 Discontinued
0.6784 Remote Similarity NPD4288 Approved
0.6784 Remote Similarity NPD2296 Approved
0.678 Remote Similarity NPD2163 Approved
0.6778 Remote Similarity NPD7549 Discontinued
0.6776 Remote Similarity NPD2981 Phase 2
0.6774 Remote Similarity NPD2861 Phase 2
0.6768 Remote Similarity NPD2354 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data